HURRICANE CAPITAL ADVISORS LLC’s Novo Nordisk NVO Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.9K	Sell	519 -8,289	-94%	-$356K	0.01%	617
2026 Q1	$324K	Buy	8,808 +2,607	+42%	+$124K	0.1%	173
2025 Q4	$316K	Buy	+6,201	New	+$317K	0.1%	168
2025 Q1	–	Sell	-16,496	Closed	-$1.42M	–	669
2024 Q4	$1.42M	Buy	+16,496	New	+$1.78M	0.41%	44
2024 Q3	–	Sell	-40,300	Closed	-$5.75M	–	618
2024 Q2	$5.75M	Buy	40,300 +20,300	+102%	+$2.69M	2.01%	12
2024 Q1	$2.57M	Buy	20,000 +19,000	+1,900%	+$2.26M	0.72%	23
2023 Q4	$103K	Buy	+1,000	New	+$98.9K	0.04%	275

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's NVO Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC reduced its Novo Nordisk (NVO) stake by 94% in Q2 2026, selling an estimated $356K and leaving 519 shares worth $24.9K. The position accounts for 0.01% of the portfolio, ranked #617.

HURRICANE CAPITAL ADVISORS LLC first reported a position in NVO in Q4 2023 and has held it in 7 quarters since. The position peaked at $5.75M in Q2 2024. 1,362 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

HURRICANE CAPITAL ADVISORS LLC held 519 shares of Novo Nordisk worth $24.9K as of Q2 2026.
HURRICANE CAPITAL ADVISORS LLC sold 8,289 Novo Nordisk shares in Q2 2026, an estimated $356K.
Novo Nordisk made up 0.01% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #617 holding.
HURRICANE CAPITAL ADVISORS LLC first reported a position in Novo Nordisk in Q4 2023 and has held it in 7 quarters since.
HURRICANE CAPITAL ADVISORS LLC's Novo Nordisk position peaked at $5.75M in Q2 2024.
1,362 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.